Dr. McCullough is an internist, cardiologist, epidemiologist holding degrees from Baylor University, University of Texas Southwestern Medical School, University of Michigan, and Southern Methodist University. He manages common infectious diseases as well as the cardiovascular complications of both the viral infection and the injuries developing after the COVID-19 vaccine in Dallas TX, USA.
He has broadly published on a range of topics in medicine with more than 1000 publications and over 685 citations in the National Library of Medicine. His works include “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” - the first widely utilized treatment regimen for ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine. He later published the first detoxification approach titled “Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes” in the Journal of American Physicians and Surgeons and the PUBMED indexed journal CUREUS. He has dozens of peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in The Hill, America Out Loud, and on FOX NEWS Channel.
Dr. McCullough testified multiple times in the US Senate, US House of Representatives, Texas Senate Committee on Health and Human Services, Arizona Senate and House of Representatives, Colorado General Assembly, New Hampshire Senate, Pennsylvania Senate, and South Carolina Senate concerning many aspects of the pandemic response. He has had years of dedicated academic and clinical efforts in combating the SARS-CoV-2 virus and in doing so, has reviewed thousands of reports, participated in scientific congresses, group discussions, press releases, and has been considered among the world's experts on COVID-19.
Links to the journal articles:
https://pubmed.ncbi.nlm.nih.gov/32771461/
https://pubmed.ncbi.nlm.nih.gov/33387997/
https://zenodo.org/record/8286460
https://pubmed.ncbi.nlm.nih.gov/38024037/
Acute COVID-19 has a great range of clinical severity from asymptomatic to fatal.
In the absence of clinical trials and guidelines, and with hospitalizations and mortality mounting, we must deploy treatment for COVID-19 based on pathophysiological principles.
As a result, Dr. McCullough developed a renowned protocol based on age and co-morbidities that allows for many people to be monitored and treated at home during self-isolation -- reducing the risks of hospitalization and death.
The spike protein is responsible for the pathogenicity of the SARS-CoV-2 infection and drives the development of adverse events, injuries, disabilities, and death after vaccination through immunologic and thrombotic mechanisms. The long-lasting spike protein has been found in the brain, heart, liver, kidneys, ovaries, testicles, and other vital organs at autopsy in cases of death after vaccination. In the case of vaccine-induced thrombotic injury, the spike protein has been found within the blood clot itself. Thus, there is strong rationale for considering residual SARS-CoV-2 spike protein as a treatment target in post COVID-19 and vaccine injury syndromes. The spike protein participates directly in pathophysiology, incites inflammation, and propels thrombosis. While specific syndromes (cardiovascular, neurological, endocrine, thrombotic, immunological) will require additional therapies, we propose the clinical rationale for a base detoxification regimen of oral nattokinase, bromelain, and curcumin for patients with post-acute sequalae from SARS-CoV-2 infection and COVID-19 vaccination.
The empiric regimen can be continued for 3-12 months or more and be guided by clinical parameters:
- Nattokinase 2000 FU (100) mg orally twice a day without food
- Bromelain 500 mg orally once a day without food
- Curcumin 500 mg orally twice a day (nano, liposomal, or with piperine additive suggested)
This is the story of doctors who developed a safe and effective early treatment for COVID-19 and their battle with the Bio-Pharmaceutical Complex that suppressed it.
Buy Now
Dr. McCullough's educational and professional approach always emphasizes understanding the science - the definitive data - so that he can work with other healthcare professionals to improve lives, save lives, and most importantly prevent people from falling ill in the first place.
As a founding member of The Wellness Company's Chief Medical Board, Dr. McCullough leads a team charged with delivering innovative science-based medical treatments and products to patients. Through his guidance as The Wellness Company's Chief Scientific Officer, The Wellness Company offers stands as source of preventative health beyond the traditional medical industrial complex, which profits from sickness.
Become a Member at The Wellness Company to take control of your health and wellness.
Connect with Dr. McCullough on his Substack and get the information you need and access treatments designed by Dr. McCullough without censorship.
Subscribe
Dr. Peter A. McCullough
US Congressional Hearing, Rayburn Building, Capitol Hill, January 12, 2024: Representative Marjorie Taylor Greene (R-GA), Senator Ron Johnson (R-WI), US Representatives Warren Davidson (R-Ohio), and Any Biggs (R-AZ), expert witnesses were Dr. Peter McCullough adult internal medicine, cardiology, Dr. Ryan Cole, clinical pathology, and Dr. Kirk Milhoan, pediatrics, pediatric cardiology.
See more
.jpg)
